Enveric Biosciences Reports Financial Results for Third Quarter 2026 and Provides Corporate Update
EB-003 Development Highlights: Advancing final IND-enabling activities to support the planned EB-003
EB-003 Development Highlights: Advancing final IND-enabling activities to support the planned EB-003